Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum B2 microglobulin (B2M) in CAPD.

E Duranti1, M Sasdelli

  • 1Divisione Di Nefrologia E Dialisi Ospedale Di Arezzo, Italia.

Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.

Cell death & disease·2015
Same author

Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions.

Nitric oxide : biology and chemistry·2015
Same author

Effect of acute and chronic vitamin D administration on systemic renin angiotensin system in essential hypertensives and controls.

Journal of endocrinological investigation·2013
Same author

Polymethylmethacrylate strengthens antibody response in hemodialysis patients not responding to hepatitis B vaccine: preliminary data.

Minerva medica·2011
Same author

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.

Cell death and differentiation·2011
Same author

Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients.

Atherosclerosis·2009
Same journal

Treatment of a Dialysate Leak by Simultaneous Catheter Removal and Replacement in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

A Rare Complication During Percutaneous Peritoneal Dialysis Catheter Insertion: Intravesical Placement.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

Is It Safe to Initiate Peritoneal Dialysis Treatment Immediately After Percutaneous Catheter Placement?

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

Better Healing of the Exit Site with Negative-Pressure Wound Therapy.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

When Love Hurts, It Leaves No Options! An Unusual Case of Pasteurella Peritoneal Dialysis Peritonitis Causing Severe Intra-abdominal Adhesions Preventing a Future Peritoneal Dialysis Option.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

Neisseria mucosa Peritonitis in the Setting of a Migrated Intrauterine Device.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
See all related articles

Serum beta-2 microglobulin (B2M) levels in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) are influenced by residual renal function and peritonitis. Lower B2M levels correlate with better renal function and fewer peritonitis episodes.

Area of Science:

  • Nephrology
  • Biochemistry
  • Clinical Medicine

Background:

  • Chronic uremic patients on CAPD often exhibit elevated serum B2M levels.
  • Beta-2 microglobulin (B2M) is a protein that can deposit in tissues, potentially causing pathology.
  • Understanding factors influencing B2M levels is crucial for managing CAPD patients.

Purpose of the Study:

  • To investigate the impact of residual renal function and peritonitis on serum B2M levels in CAPD patients.
  • To explore potential correlations between clinical factors and B2M levels in this population.

Main Methods:

  • Study included 26 chronic uremic patients on CAPD.
  • Serum B2M levels were measured using radioimmunoassay.
  • Patients were grouped based on residual renal function (diuresis ≥ 500 cc/day vs. < 500 cc/day) and peritonitis history.

Related Experiment Videos

Main Results:

  • Serum B2M levels were significantly lower in patients with residual renal function (diuresis ≥ 500 cc/day).
  • Patients without peritonitis episodes exhibited significantly lower serum B2M levels.
  • No significant relationship was found between B2M levels and primary renal diseases, sex, or age.

Conclusions:

  • Residual renal function and peritonitis episodes are significant factors influencing serum B2M levels in CAPD patients.
  • Further long-term follow-up is warranted to clarify the role of these factors in B2M deposition-related pathologies.